Results 61 to 70 of about 7,752 (219)

Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine

Drug Design, Development and Therapy, 2016
Gianni Allais, Chiara Benedetto Department of Surgical Sciences, Women’s Headache Center, University of Turin, Turin, Italy Abstract: Migraine is a common neurovascular disorder, affecting millions of people worldwide.
Allais G, Benedetto C
doaj  

Strategies for Treating Acute Migraines and Identifying Triggers. Literature review

Journal of Education, Health and Sport
Introduction Migraine, a prevalent neurological disorder affecting a substantial portion of the global population, poses a significant burden on individuals' overall quality of life.
Zuzanna Kotowicz, Jakub Pabiś, Piotr Podgórski, Sandra Górecka, Miłosz Olszański, Aleksander Bogusz, Oskar Kwiatkowski, Anna Kołodziej, Anita Król   +8 more
doaj   +1 more source

Novel pharmaceutical dosage forms of analgesics [PDF]

Arhiv za farmaciju, 2019
Among novel pharmaceutical dosage forms of analgesics, whose number and diversity are continuously increasing over the past two decades, of particular importance are transdermal opioid analgesics (fentanyl, buprenorphine) for the treatment of chronic ...
Đekić Ljiljana, Primorac Marija
doaj  

Could calcitonin gene‐related peptide inhibitors prevent status epilepticus?

Epilepsia, Volume 67, Issue 10, Page e198-e201, October 2026.
Abstract Calcitonin gene‐related peptide (CGRP) inhibitors modulate pain and neuroinflammation, a recognized contributor to epileptogenesis and status epilepticus (SE). We examined the association between CGRP inhibitor use and SE hospitalization in epilepsy patients with comorbid migraine.
Michael Nsaka, Noor Baban, Sepideh Allahdadian, Armin Scheffler, Diana Lindner, Dagny Holle, Alain Lekoubou   +6 more
wiley   +1 more source

Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study

Brain Sciences, 2020
Background: Medical cannabis (MC) treatment for migraine is practically emerging, although sufficient clinical data are not available for this indication.
Joshua Aviram, Yelena Vysotski, Paula Berman, Gil M. Lewitus, Elon Eisenberg, David Meiri   +5 more
doaj   +1 more source

G Protein‐Coupled Receptor in High‐Altitude Diseases: Mechanistic Insights and Therapeutic Opportunities

MedComm, Volume 7, Issue 10, October 2026.
High‐altitude hypobaric hypoxia activates multiorgan GPCR signaling networks that regulate ventilatory responses, cerebral endothelial barrier integrity, erythropoiesis and red blood cell metabolism, pulmonary vascular remodeling, and cardiac adaptation. Dysregulated GPCR pathways contribute to acute and chronic high‐altitude diseases, while clinically
Qing Zhao, Changliang Liu, Lu Dai, Kun Zheng, Kun Liang, Chuanling Pan, Lianhua Liu, Ling Chen, Xuefei He, Hui Yan, Lei Chen, Huaping Zheng, Cheng Deng, Fengming Luo   +13 more
wiley   +1 more source

Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis

, 2021
Objective: To determine the potential efficacy of ubrogepant for acute treatment of migraine based on historical experience with triptans. Background: Although triptans have improved migraine treatment, their efficacy and tolerability may limit their ...
Liu, Chengcheng, Armin Szegedi, Finnegan, Michelle, Peter J. Goadsby, Michelle Finnegan, Blumenfeld, Andrew M., Joel M. Trugman, Hutchinson, Susan, Trugman, Joel M., Szegedi, Armin, Goadsby, Peter J.; id_orcid, Dodick, David W., Susan Hutchinson, Chengcheng Liu, Andrew M. Blumenfeld, David W. Dodick   +15 more
core   +1 more source

Efficacy and safety of Russian tableted rizatriptan 10 mg in the treatment of migraine attacks in clinical practice

Неврология, нейропсихиатрия, психосоматика
Triptans are a targeted therapy for acute migraine attacks. They are recommended for the treatment of severe attacks when non-specific analgesics are not effective.
E. G. Filatova, N. V. Latysheva, N. B. Kadymova, A. V. Berdnikova   +3 more
doaj   +1 more source

Migraine in Older Adults: Age‐Related Clinical Features From the Italian RICe Registry

European Journal of Neurology, Volume 33, Issue 10, October 2026.
This multicentre study of 3477 patients from 30 Italian headache centres identified distinct age‐related patterns in migraine. Older adults more frequently presented with chronic migraine, higher monthly migraine frequency, lower pain intensity, and medication‐overuse headache, as well as distinct trigger and preventive treatment patterns.
Giulia Paparella, Luigi Francesco Iannone, Giulia Paparella, Grazia Sances, Roberto De Icco, Gloria Vaghi, Cristina Tassorelli, Andrea Burgalassi, Francesco De Cesaris, Alberto Chiarugi, Francesca Gabriele, Raffaele Ornello, Simona Sacco, Maria Pia Prudenzano, Martino Gentile, Damiano Paolicelli, Giorgia Dalla Volta, Marco Bolchini, Innocenzo Rainero, Elisa Rubino, Maria Albanese, Fabrizio Vernieri, Gianluca Coppola, Gianluca Avino, Edoardo Mampreso, Delfina Ferrandi, Marta Altieri, Stefania Battistini, Antonio Granato, Simona Guerzoni, Antonio Russo, Marina de Tommaso, the RICe Study Group, Paola Merlo, Alessandro Viganò, Massimo Alessandri, Lucia Princiotta Cariddi, Milena Taglioli, Mariarosaria Valente, Rosaria Rapisarda, Alessandro Tiezzi, Giovanna Ballerini, Giovanna Viticchi, Catello Vollono, Luisa Fofi, Antonio Montisano, Licia Grazzi, Eugenia Rota   +47 more
wiley   +1 more source

The triptan formulations: a critical evaluation Formulações dos triptanos: avaliacão crítica

Arquivos de Neuro-Psiquiatria, 2003
The migraine-specific triptans have revolutionized the treatment of migraine and are usually the drugs of choice to treat a migraine attack in progress.
Marcelo E. Bigal, Carlos A. Bordini, Ana L. Antoniazzi, José G. Speciali   +3 more
doaj   +1 more source